A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular Juvenile Idiopathic Arthritis
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Pharmacokinetics
- Acronyms JIGSAW 117
- Sponsors Roche
- 01 Sep 2016 Status changed from active, no longer recruiting to completed.
- 18 Aug 2016 This trial is completed in Poland (end date:2016-05-19) as per European Clinical Trials Database record.
- 08 Jun 2016 This trial is completed in Spain (end date:2016-05-19) and Germany as per European Clinical Trials Database record.